| Kay Dawn Martens, FNP-C, PMHNP-BC | |
|
334 E 200 S, Burley, ID 83318-5433 | |
| (208) 260-0961 | |
| Not Available |
| Full Name | Kay Dawn Martens |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 334 E 200 S, Burley, Idaho |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538708862 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 63267 (Idaho) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Canvi Behavioral Health Pllc | 0941692073 | 11 |
News Archive
A Task Force of the European Society of Hypertension have released the official European guidelines on the management and treatment of hypertension. The guidelines are an update of those published in 2007, and will be published in the November issue of the Journal of Hypertension.
Pfizer Oncology will present new data highlighting the company's focused approach to cancer drug development through the identification and validation of molecular targets. These results will be presented at the 46th Annual American Society of Clinical Oncology meeting in Chicago from June 4-8.
When a pregnant woman leans back, and shifts her weight to stand more comfortably, she is performing a motion that for millions of years has helped to compensate for the strain and weight of childbearing on the body.
Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Repaglinide Tablets, 0.5 mg, 1 mg and 2 mg. This product is the generic version of Novo Nordisk's Prandin, which is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
› Verified 7 days ago
| Entity Name | Imhealth Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114599321 PECOS PAC ID: 6800294810 Enrollment ID: O20211005003677 |
News Archive
A Task Force of the European Society of Hypertension have released the official European guidelines on the management and treatment of hypertension. The guidelines are an update of those published in 2007, and will be published in the November issue of the Journal of Hypertension.
Pfizer Oncology will present new data highlighting the company's focused approach to cancer drug development through the identification and validation of molecular targets. These results will be presented at the 46th Annual American Society of Clinical Oncology meeting in Chicago from June 4-8.
When a pregnant woman leans back, and shifts her weight to stand more comfortably, she is performing a motion that for millions of years has helped to compensate for the strain and weight of childbearing on the body.
Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Repaglinide Tablets, 0.5 mg, 1 mg and 2 mg. This product is the generic version of Novo Nordisk's Prandin, which is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
› Verified 7 days ago
| Entity Name | Canvi Behavioral Health Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144984873 PECOS PAC ID: 0941692073 Enrollment ID: O20220121000627 |
News Archive
A Task Force of the European Society of Hypertension have released the official European guidelines on the management and treatment of hypertension. The guidelines are an update of those published in 2007, and will be published in the November issue of the Journal of Hypertension.
Pfizer Oncology will present new data highlighting the company's focused approach to cancer drug development through the identification and validation of molecular targets. These results will be presented at the 46th Annual American Society of Clinical Oncology meeting in Chicago from June 4-8.
When a pregnant woman leans back, and shifts her weight to stand more comfortably, she is performing a motion that for millions of years has helped to compensate for the strain and weight of childbearing on the body.
Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Repaglinide Tablets, 0.5 mg, 1 mg and 2 mg. This product is the generic version of Novo Nordisk's Prandin, which is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kay Dawn Martens, FNP-C, PMHNP-BC 334 E 200 S, Burley, ID 83318-5433 Ph: (208) 260-0961 | Kay Dawn Martens, FNP-C, PMHNP-BC 334 E 200 S, Burley, ID 83318-5433 Ph: (208) 260-0961 |
News Archive
A Task Force of the European Society of Hypertension have released the official European guidelines on the management and treatment of hypertension. The guidelines are an update of those published in 2007, and will be published in the November issue of the Journal of Hypertension.
Pfizer Oncology will present new data highlighting the company's focused approach to cancer drug development through the identification and validation of molecular targets. These results will be presented at the 46th Annual American Society of Clinical Oncology meeting in Chicago from June 4-8.
When a pregnant woman leans back, and shifts her weight to stand more comfortably, she is performing a motion that for millions of years has helped to compensate for the strain and weight of childbearing on the body.
Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Repaglinide Tablets, 0.5 mg, 1 mg and 2 mg. This product is the generic version of Novo Nordisk's Prandin, which is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
› Verified 7 days ago
Shaylynn Sherrick Smith, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2303 Park Ave, Burley, ID 83318 Phone: 208-677-3073 | |
Amy Lou Jensen, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1404 Pomerelle Ave Ste A1, Burley, ID 83318 Phone: 208-878-8783 Fax: 208-878-8786 | |
Ms. Ann Cueva, RNCFNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1252 Bennett Ave, Suite B, Burley, ID 83318 Phone: 208-878-3486 Fax: 208-878-2005 | |
Mr. Scott Michael Cook, APRN-CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1501 Hiland Ave, Burley, ID 83318 Phone: 208-678-4444 | |
Cindy Hurst, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1700 Overland Ave, Burley, ID 83318 Phone: 208-825-6193 Fax: 208-825-6199 | |
Daelynn Jo Smith, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1404 Pomerelle Ave, Suite B, Burley, ID 83318 Phone: 208-878-9432 Fax: 208-878-4576 | |
Lyndsie Chatburn, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1309 Bennett Ave, Burley, ID 83318 Phone: 208-678-7796 Fax: 208-678-7799 |